FDA Inspection 1031865 — Stuart Jones
The FDA completed an inspection of Stuart Jones on Nov 3, 2017 in Auckland. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 3, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Auckland (New Zealand)
Additional Details
Clinical Investigator (CI)